Remy Luthringer, CEO at Minerva Neurosciences, Inc. (NERV), sold 51,147 shares at $3.85 ($197K) on 2023-05-01, disclosed to the SEC on 2023-05-02.
Open-market sale of $197k NERV by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.85 | 23,753 | $91K | 46.5% |
| 2 | $3.85 | 23,753 | $91K | 46.5% |
| 3 | $3.76 | 3,641 | $14K | 7.0% |
| Total | $3.84 avg | 51,147 | $197K | 100% |
| Filing → |
| NERV | SELL | 2018-12-18 | $19K | — | Filing → |
| NERV | SELL | 2017-12-15 | $13K | — | Filing → |
| NERV | SELL | 2017-02-07 | $378K | — | Filing → |